Dr Martens PLC
LSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Dr Martens PLC (DOCS) under the Base Case is 71.06 GBX per share.
Compared with the current market price of 52.2 GBX, the stock appears
Undervalued by 27% .
The intrinsic value is calculated using the DCF method. The model assumes revenue returns to growth: about 4% a year over the next five years, after falling about 0% a year over the last five years. If revenue grew at its five-year pace of 0%, the estimate would be about GBX 59. The value of the years after 2031 is tied to revenue, so margins count only until then.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Dr Martens Does
Dr Martens makes and sells boots, shoes, sandals, and some accessories under the Dr. Martens brand. Its best-known products are the leather lace-up boots with thick soles, which are bought by people who want a durable, recognizable style as well as practical footwear. The company also sells into workwear and casual fashion, but its core identity comes from that one iconic boot shape and brand image.
- Headquarters
- United Kingdom UK
- Employees
- 2 348
- IPO date
- Jan 29, 2021
Dr Martens has no economic moat
Dr Martens PLC lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
A disappointing first half, driven mainly by boots and unusually hot weather, leaves Dr. Martens focused on executing its strategy and the key trading weeks ahead.
Open the earnings call- Stock, next trading day
- −2.4%
Past 12 months
Continue DOCS Research
Decided on Dr Martens? Get an email when DOCS reaches the price you’d buy at. Free with an account.
Other Dr Martens listings
What is the Intrinsic Value of one DOCS stock?
The intrinsic value for
Dr Martens PLC (DOCS) under the Base Case is 71.06 GBX.
Is DOCS stock undervalued or overvalued?
Compared with the current market price of 52.2 GBX, the stock appears Undervalued by 27% .